, Lena Hauberg-Lotte , Stephanie Devaux [a] , Zahra Laouby [a] , Celine Meriaux [a] , Antonella Raffo-Romero [a] , Melanie Rose [a] , Leie Westerheide [b] , Jost Vehmeyer [b] , Franck Rodet [a] , Peter Maass [b] , Dasa Cizkova [c,d] .552 * Grouping procedure for detection of time-point discriminative m/z: For SCI lesion at 3 days, ROC analyses using 3 day vs. 7 day and 3 day vs. 10 day comparisons were performed, and m/z common in both analyses with AUCmax > 0.80 ("above") were assigned as discriminative of the lesion at 3 days. The same approach was used to find discriminative m/z for the 7 day and 10 day time points. For SCI lesion at 7 days, m/z with AUCmax < 0.30 ("below") from the 3 day vs. 7 day comparison, and those with AUCmax > 0.70 ("above") from the 7 day vs. 10 day comparison, were used. Whereas, for SCI lesion at 10 days, m/z with AUCmax < 0.30 ("below") from the 3 day vs. 10 day and 7 day vs. 10 day comparisons were used. 
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Supplementary Figure S2 . Examples of m/z values detected in SCI lesions that are time point-discriminative based on ROC analysis (L at 3 days vs. L at 10 days). Top panels show the ion images of m/z 443.7 (discriminative of L at 3 days, ie., AUC > 0.80) and m/z 772.6 (discriminative of L at 10 days, ie., AUC < 0.30) of all sections from the L segments. Bottom panels show mean absolute intensities of the m/z intervals (highlighted in rainbow) of spectra from all imaged sections in SCI lesions at 3 days (blue) and 10 days (light violet). 10 , reproduced with permission from Elsevier). Asterisks (*) denote artifacts due to pump noise, etc., consistently observed in all spectra.
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The MS2 spectrum of the lesion-specific peak m/z 400.3 shows the prominent peaks of the precursor ion and the fragment after loss of the N-trimethylamine group (m/z 341, Figure  S5a ). The peak at m/z 239 corresponding to the loss of the glycerol backbone can also be observed as a weak signal in the MS2 spectrum. MS3 of m/z 341 yields the same fragment, confirming its presence (Figure S5a, inset) . Mass matching with the predicted mass of AC(16:0 (m/z 400.3421) further confirms the assignment, with 'ppm = 0.52 ( Figure S5b ). Likewise, Lin et al. obtained the same initial fragments in an MS2 spectrum generated on a Quatro QQQ instrument ( Figure S5c) 1 . In the same manner, assignment of AC(18:1) (m/z 426.4) was done, with 'ppm = 0.56. For AC(18:1), the fatty acid fragment after loss of glycerol (m/z 265) is already observable in MS2 (Supplementary Data 3). In the case of m/z 398.3, isolation of the precursor ion proved to be difficult. However, LIPIDMAPS database interrogation of the high-accuracy mass measurement (m/z 398.32619) suggests this mass to be AC(16:1) ('ppm = 0.78), the mono-unsaturated form of AC(16:0). m/z 398.3 is also lesion-specific and co-localizes with m/z 400.3. m/z 372.3 was also identified as another acylcarnitine member, AC(14:0) ('ppm = 1.80); in this case only the N-trimethylamine and -COOH losses were observed. m/z 372.3 was identified as lesion-discriminative by ROC analysis. Peaks co-localized in the gray matter and white matter regions were also assigned, where possible; following lithium adduct formation a (Supplementary File 2). 
